ANGELA MEHLER: Open Payments
NPI 1316362833 · UNION, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,182 in 101 payments from 12 companies in 2025. Trend: 2023 $22 · 2024 $857 · 2025 $4,182
Food & beverage: $1,817Honoraria: $1,280Travel & lodging: $1,084
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 26 | $2,899 |
| Indivior Inc. | 15 | $236 |
| Alkermes, Inc. | 12 | $226 |
| Axsome Therapeutics, Inc. | 12 | $180 |
| ABBVIE INC. | 9 | $160 |
| Vanda Pharmaceuticals Inc. | 9 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
Products named: BRIXADI, SUBLOCADE, Auvelity, VIVITROL, VRAYLAR, FANAPT, XIFAXAN, CAPLYTA.
Industry payments across MO — which companies pay providers there.
